Literature DB >> 9370229

Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord.

H S Keirstead1, W F Blakemore.   

Abstract

In order to investigate the remyelinating potential of mature oligodendrocytes in vivo, we have developed a model of demyelination in the adult rat spinal cord in which some oligodendrocytes survive demyelination. A single intraspinal injection of complement proteins plus antibodies to galactocerebroside (the major myelin sphingolipid) resulted in demyelination followed by oligodendrocyte remyelination. Remyelination was absent when the spinal cord was exposed to 40 Grays of x-irradiation prior to demyelination, a procedure that kills dividing cells. Quantitative Rip immunohistochemical analysis revealed a similar density of surviving oligodendrocytes in x-irradiated and nonirradiated lesions 3 days after demyelination. Rip and bromodeoxyuridine double immunohistochemical analysis of demyelinated lesions indicated that Rip+ oligodendrocytes did not divide as an acute response to demyelination. Oligodendrocytes were also identified by Rip immunostaining and electron microscopy at late time points (3 weeks) within x-irradiated areas of demyelination. These oligodendrocytes extended processes that engaged axons, and on occasion formed myelin membranes, but did not lay down new myelin sheaths. These studies demonstrate that (a) oligodendrocytes that survive within a region of demyelination are not induced to divide in the presence of demyelinated axons, and (b) fully-differentiated oligodendrocytes are therefore postmitotic and do not contribute to remyelination in the adult CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370229     DOI: 10.1097/00005072-199711000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  79 in total

1.  Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord.

Authors:  D M McTigue; P Wei; B T Stokes
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

Review 2.  Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination.

Authors:  Alejandro F De Nicola; Susana L Gonzalez; Florencia Labombarda; Maria Claudia González Deniselle; Laura Garay; Rachida Guennoun; Michael Schumacher
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  How the primate fornix is affected by age.

Authors:  Alan Peters; Claire Sethares; Mark B Moss
Journal:  J Comp Neurol       Date:  2010-10-01       Impact factor: 3.215

Review 4.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

5.  Voluntary running attenuates age-related deficits following SCI.

Authors:  Monica M Siegenthaler; Nicole C Berchtold; Carl W Cotman; Hans S Keirstead
Journal:  Exp Neurol       Date:  2007-11-13       Impact factor: 5.330

6.  Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.

Authors:  Joshua E Burda; Maja Radulovic; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

7.  Role of neuregulin-1/ErbB signaling in stem cell therapy for spinal cord injury-induced chronic neuropathic pain.

Authors:  Feng Tao; Qun Li; Su Liu; Haiying Wu; John Skinner; Andres Hurtado; Visar Belegu; Orion Furmanski; Ya Yang; John W McDonald; Roger A Johns
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

8.  Diffusion tensor imaging at 3 hours after traumatic spinal cord injury predicts long-term locomotor recovery.

Authors:  Joong H Kim; David N Loy; Qing Wang; Matthew D Budde; Robert E Schmidt; Kathryn Trinkaus; Sheng-Kwei Song
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

9.  Histone deacetylase expression in white matter oligodendrocytes after stroke.

Authors:  Haifa Kassis; Michael Chopp; Xian Shuang Liu; Amjad Shehadah; Cynthia Roberts; Zheng Gang Zhang
Journal:  Neurochem Int       Date:  2014-03-19       Impact factor: 3.921

10.  Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis.

Authors:  J Zhang; Z G Zhang; D Morris; Y Li; C Roberts; S B Elias; M Chopp
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.